ALDH |
1aldehyde dehydrogenase isoform I |
AMPK |
AMP-activated protein kinase |
ASA |
acetylsalicylic acid or aspirin |
CAF |
cancer-associated fibroblast |
CI |
combination index |
COX |
cyclooxygenase |
CSC |
cancer stem cell |
CTRL |
control |
EBP |
elastin binding protein |
ECM |
extracellular matrix |
EGFR |
epidermal growth factor receptor |
EMT |
epithelial-to-mesenchymal transition |
GEM |
gemcitabine |
GPCR |
G-protein coupled receptor |
HuVEC |
human umbilical vein endothelial cell |
IC50 |
half-maximal inhibitory concentration |
IR |
insulin receptor |
LC3-II |
light chain 3-II |
MMP-9 |
matrix metalloproteinase-9 |
mTOR |
mammalian target of rapamycin |
Neu-1 |
neuraminidase-1 |
NGF |
nerve growth factor |
NSAID |
non-steroidal anti-inflammatory drug |
OP |
oseltamivir phosphate |
PDAC |
pancreatic ductal adenocarcinoma; |
PI |
propidium iodide |
PPCA |
cathepsin-binding protein |
PS |
phosphatidylserine |
RFU |
relative fluorescent units |
RTK |
receptor tyrosine kinase |
RWD |
relative wound density |
TLR |
TOLL-like receptor |
TME |
tumor microenvironment; Tmx; tamoxifen |
TNBC |
triple-negative breast cancer |